![Sofia Ioannidou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sofia Ioannidou
Investitore di Private Equity presso
Andera Partners SCA
Profilo
Sofia Ioannidou is a Partner at Andera Partners SCA since 2019, with employment at the firm starting in 2009.
Former positions include Director at Cellnovo Group SA, Director at TRiCares SAS, Independent Director at LogicBio Therapeutics, Inc. from 2017 to 2019, and Director at Avalyn Pharma, Inc. Education includes undergraduate and graduate degrees from the University of Oxford conferred in 2000, and a doctorate from University College London conferred in 2004.
Posizioni attive di Sofia Ioannidou
| Società | Posizione | Inizio |
|---|---|---|
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Investitore di Private Equity | 01/03/2013 |
Precedenti posizioni note di Sofia Ioannidou
| Società | Posizione | Fine |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 25/06/2019 |
| AVALYN PHARMA INC. | Direttore/Membro del Consiglio | - |
TRiCares SAS
 TRiCares SAS Medical SpecialtiesHealth Technology Commercializes medical device | Direttore/Membro del Consiglio | - |
| CELLNOVO | Direttore/Membro del Consiglio | - |
Formazione di Sofia Ioannidou
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partners invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Finance |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
TRiCares SAS
TRiCares SAS Medical SpecialtiesHealth Technology Commercializes medical device | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
